Medtronic Investors Sue Over Insulin Pump Recall, FDA Letter
By Elliot Weld · September 9, 2022, 5:34 PM EDT
Medtronic was hit with a proposed class action Thursday by a group of pension funds alleging the medical device manufacturer hid that its insulin pumps were defective, causing its stock to...
To view the full article, register now.